SunCoke Energy (SXC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 Annual Meeting will be held virtually on May 15, 2025, with voting on director elections, executive compensation, and auditor ratification.
The company reported strong operational and financial performance in 2024, including record safety results and full capacity utilization in core businesses.
A significant agreement with the Department of Labor eliminated most legacy black lung liabilities, resulting in a $9.5 million pre-tax gain and reduced future expenses.
Capital allocation priorities were maintained, with $37.6 million returned to shareholders and a 20% dividend increase.
Voting matters and shareholder proposals
Shareholders will vote to elect two directors (Arthur F. Anton and Michael W. Lewis) for terms expiring in 2028.
An advisory vote on executive compensation (say-on-pay) and ratification of KPMG LLP as independent auditor for 2025 are on the agenda.
The board recommends voting FOR all proposals.
Board of directors and corporate governance
The board consists of seven members, six of whom are independent; all committees are fully independent.
The board is divided into three classes with staggered three-year terms; recent refreshment included five new directors in five years.
The governance committee oversees director nominations, succession, and annual board evaluations.
The board separates the roles of Chairman and CEO, with an independent Chairman providing oversight.
Stock ownership guidelines and annual self-evaluations are in place for directors.
Latest events from SunCoke Energy
- 2026 outlook projects EBITDA and FCF growth after a challenging 2025 with one-time impacts.SXC
Q4 202517 Feb 2026 - Q3 adjusted EBITDA hit $75.3M, net income rose, and 2024 guidance was raised on regulatory gain.SXC
Q3 202413 Feb 2026 - Q2 Adjusted EBITDA hit $63.5M, with a 20% dividend hike and strong full-year outlook.SXC
Q2 20242 Feb 2026 - 2024 Adjusted EBITDA exceeded guidance; 2025 faces margin pressure but strong liquidity persists.SXC
Q4 20249 Jan 2026 - Virtual meeting to elect directors, approve pay, and ratify auditor on May 15, 2025.SXC
Proxy Filing1 Dec 2025 - Q1 2025 profit fell on weak coke sales, but guidance and liquidity remain strong.SXC
Q1 202528 Nov 2025 - $325M acquisition expands reach, diversifies earnings, and delivers immediate accretion and synergies.SXC
M&A Announcement25 Nov 2025 - Q2 2025 earnings fell, but liquidity is strong and a $325M acquisition closes August 1.SXC
Q2 202516 Nov 2025 - Q3 2025 Adjusted EBITDA dropped to $59.1M, with FY guidance cut to $220–$225M after a contract breach.SXC
Q3 202513 Nov 2025